Media headlines about Franklin Covey (NYSE:FC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Franklin Covey earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.5725768898916 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Franklin Covey : to Report Fourth-Quarter and Full-Year Fiscal 2017 Results (4-traders.com)
- Franklin Covey to Report Fourth-Quarter and Full-Year Fiscal 2017 Results (finance.yahoo.com)
- AREA ROUNDUP: Pirates, Lady Pirates, Bulldogs advance from cross country regional (mywebtimes.com)
- O&P providers receive Freedom Award for service to veterans (healio.com)
- Second medical marijuana business seeks to open in Attleboro (thesunchronicle.com)
A number of analysts have recently weighed in on the company. Zacks Investment Research upgraded Franklin Covey from a “sell” rating to a “hold” rating in a research note on Monday, September 4th. BidaskClub lowered Franklin Covey from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $22.00.
Shares of Franklin Covey (NYSE:FC) traded up 1.82% during mid-day trading on Tuesday, reaching $19.55. The company had a trading volume of 4,786 shares. The company’s market cap is $270.94 million. Franklin Covey has a 52-week low of $15.20 and a 52-week high of $22.45. The firm’s 50-day moving average price is $19.46 and its 200 day moving average price is $19.55.
In other Franklin Covey news, Director Joel Clinton Peterson sold 1,792 shares of the company’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $18.59, for a total value of $33,313.28. Following the completion of the transaction, the director now owns 227,072 shares of the company’s stock, valued at approximately $4,221,268.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 33.50% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2017/10/31/franklin-covey-fc-given-daily-media-sentiment-rating-of-0-10.html.
About Franklin Covey
Franklin Covey Co is a global company specializing in performance improvement. The Company’s segments are Direct Offices, Strategic Markets, Education practice and International Licensees. The Direct Offices segment consists of its geographic sales offices that serve the United States and Canada, its international sales offices located in Japan, the United Kingdom and Australia, and its public programs group.
What are top analysts saying about Franklin Covey Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Franklin Covey Company and related companies.